Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Robyn Karnauskas's Stock Ratings
Truist Securities Analyst
Robyn Karnauskas is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025
Overall Average Return
-1.40%
Smart Score
Overall Average Return Percentile
34th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/16/2025 | ABCL | Buy Now | AbCellera Biologics | $3.50 | 185.72% | Robyn Karnauskas54% | $28 → $10 | Maintains | Buy | Get Alert |
| 01/08/2025 | AMGN | Buy Now | Amgen | $289.00 | 3.11% | Robyn Karnauskas54% | $333 → $298 | Maintains | Hold | Get Alert |
| 01/08/2025 | BMY | Buy Now | Bristol-Myers Squibb | $46.98 | 38.36% | Robyn Karnauskas54% | $62 → $65 | Maintains | Buy | Get Alert |
| 01/08/2025 | MRK | Buy Now | Merck & Co | $78.70 | 39.77% | Robyn Karnauskas54% | $130 → $110 | Downgrade | Buy → Hold | Get Alert |
| 11/07/2024 | MRK | Buy Now | Merck & Co | $78.70 | 65.18% | Robyn Karnauskas54% | $132 → $130 | Maintains | Buy | Get Alert |
| 10/14/2024 | AMGN | Buy Now | Amgen | $289.00 | 15.22% | Robyn Karnauskas54% | $320 → $333 | Downgrade | Buy → Hold | Get Alert |
| 10/09/2024 | MRK | Buy Now | Merck & Co | $78.70 | 67.73% | Robyn Karnauskas54% | $143 → $132 | Maintains | Buy | Get Alert |
| 08/15/2024 | GILD | Buy Now | Gilead Sciences | $108.90 | -23.78% | Robyn Karnauskas54% | $82 → $83 | Maintains | Hold | Get Alert |
| 07/26/2024 | ABBV | Buy Now | AbbVie | $185.00 | 13.51% | Robyn Karnauskas54% | $195 → $210 | Reiterates | Buy → Buy | Get Alert |
| 06/11/2024 | BMEA | Buy Now | Biomea Fusion | $1.94 | — | Robyn Karnauskas54% | — | Downgrade | Buy → Hold | Get Alert |
| 05/16/2024 | BIIB | Buy Now | Biogen | $126.54 | 168.69% | Robyn Karnauskas54% | $340 → $340 | Maintains | Buy | Get Alert |
| 05/15/2024 | CRIS | Buy Now | Curis | $2.26 | 1050.44% | Robyn Karnauskas54% | $26 → $26 | Maintains | Buy | Get Alert |
| 05/13/2024 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 814.84% | Robyn Karnauskas54% | $8 → $7 | Maintains | Buy | Get Alert |
| 04/26/2024 | MRK | Buy Now | Merck & Co | $78.70 | 81.7% | Robyn Karnauskas54% | $142 → $143 | Maintains | Buy | Get Alert |
| 04/12/2024 | AMGN | Buy Now | Amgen | $289.00 | 10.73% | Robyn Karnauskas54% | $320 → $320 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 121% | Robyn Karnauskas54% | $1135 → $1135 | Maintains | Buy | Get Alert |
| 04/01/2024 | BMEA | Buy Now | Biomea Fusion | $1.94 | 2735.05% | Robyn Karnauskas54% | → $55 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | MRK | Buy Now | Merck & Co | $78.70 | 80.43% | Robyn Karnauskas54% | $139 → $142 | Reiterates | Buy → Buy | Get Alert |
| 03/26/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 121% | Robyn Karnauskas54% | $1135 → $1135 | Maintains | Buy | Get Alert |
| 03/26/2024 | OABI | Buy Now | OmniAb | $1.73 | 478.03% | Robyn Karnauskas54% | → $10 | Maintains | Buy | Get Alert |
| 03/26/2024 | ABSI | Buy Now | Absci | $2.78 | 223.74% | Robyn Karnauskas54% | $9 → $9 | Maintains | Buy | Get Alert |
| 03/25/2024 | TRML | Buy Now | Tourmaline Bio | $16.16 | 357.92% | Robyn Karnauskas54% | → $74 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | ROIV | Buy Now | Roivant Sciences | $11.35 | 102.64% | Robyn Karnauskas54% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | IMVT | Buy Now | Immunovant | $15.86 | 202.65% | Robyn Karnauskas54% | → $48 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | BIIB | Buy Now | Biogen | $126.54 | 168.69% | Robyn Karnauskas54% | → $340 | Reiterates | Buy → Buy | Get Alert |
| 03/25/2024 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 487.54% | Robyn Karnauskas54% | → $50 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2024 | LLY | Buy Now | Eli Lilly and Co | $782.91 | 8.57% | Robyn Karnauskas54% | → $850 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | ABSI | Buy Now | Absci | $2.78 | 223.74% | Robyn Karnauskas54% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 02/22/2024 | GILD | Buy Now | Gilead Sciences | $108.90 | -24.7% | Robyn Karnauskas54% | $91 → $82 | Downgrade | Buy → Hold | Get Alert |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $782.91 | 8.57% | Robyn Karnauskas54% | $650 → $850 | Maintains | Buy | Get Alert |
| 02/06/2024 | ABBV | Buy Now | AbbVie | $185.00 | 5.41% | Robyn Karnauskas54% | $180 → $195 | Maintains | Buy | Get Alert |
| 02/06/2024 | BMEA | Buy Now | Biomea Fusion | $1.94 | 2735.05% | Robyn Karnauskas54% | → $55 | Initiates | → Buy | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $78.70 | 76.62% | Robyn Karnauskas54% | $122 → $139 | Maintains | Buy | Get Alert |
| 01/31/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | 13.29% | Robyn Karnauskas54% | $456 → $508 | Maintains | Buy | Get Alert |
| 01/23/2024 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 945.53% | Robyn Karnauskas54% | $12 → $8 | Maintains | Buy | Get Alert |
| 12/18/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 103.47% | Robyn Karnauskas54% | → $1045 | Reiterates | Buy → Buy | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $23.87 | 50.82% | Robyn Karnauskas54% | $42 → $36 | Maintains | Buy | Get Alert |
| 12/04/2023 | PFE | Buy Now | Pfizer | $23.87 | 75.95% | Robyn Karnauskas54% | → $42 | Reiterates | Buy → Buy | Get Alert |
| 11/29/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 103.47% | Robyn Karnauskas54% | → $1045 | Reiterates | Buy → Buy | Get Alert |
| 11/29/2023 | LLY | Buy Now | Eli Lilly | $782.91 | -16.98% | Robyn Karnauskas54% | → $650 | Reiterates | Buy → Buy | Get Alert |
| 11/29/2023 | AMGN | Buy Now | Amgen | $289.00 | 10.73% | Robyn Karnauskas54% | → $320 | Reiterates | Buy → Buy | Get Alert |
| 11/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 103.47% | Robyn Karnauskas54% | → $1045 | Reiterates | Buy → Buy | Get Alert |
| 11/28/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 1468.29% | Robyn Karnauskas54% | → $12 | Reiterates | Buy → Buy | Get Alert |
| 11/17/2023 | CRIS | Buy Now | Curis | $2.26 | 1050.44% | Robyn Karnauskas54% | → $26 | Initiates | → Buy | Get Alert |
| 11/17/2023 | TRML | Buy Now | Tourmaline Bio | $16.16 | 166.09% | Robyn Karnauskas54% | → $43 | Initiates | → Buy | Get Alert |
| 11/15/2023 | IMVT | Buy Now | Immunovant | $15.86 | 202.65% | Robyn Karnauskas54% | $30 → $48 | Maintains | Buy | Get Alert |
| 11/02/2023 | AMGN | Buy Now | Amgen | $289.00 | 10.73% | Robyn Karnauskas54% | → $320 | Upgrade | Hold → Buy | Get Alert |
| 10/17/2023 | PFE | Buy Now | Pfizer | $23.87 | 75.95% | Robyn Karnauskas54% | $62 → $42 | Maintains | Buy | Get Alert |
| 10/10/2023 | RYZB | Buy Now | RayzeBio | — | — | Robyn Karnauskas54% | → $29 | Initiates | → Buy | Get Alert |
| 10/06/2023 | BMY | Buy Now | Bristol-Myers Squibb | $46.98 | 78.81% | Robyn Karnauskas54% | → $84 | Reiterates | Buy → Buy | Get Alert |
| 10/06/2023 | MRK | Buy Now | Merck & Co | $78.70 | 55.02% | Robyn Karnauskas54% | → $122 | Reiterates | Buy → Buy | Get Alert |
| 10/06/2023 | PTCT | Buy Now | PTC Therapeutics | $49.60 | -49.6% | Robyn Karnauskas54% | → $25 | Downgrade | Buy → Hold | Get Alert |
| 10/05/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.73 | — | Robyn Karnauskas54% | — | Downgrade | Buy → Hold | Get Alert |
| 10/04/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | 1.69% | Robyn Karnauskas54% | → $456 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 2513.82% | Robyn Karnauskas54% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | 102.64% | Robyn Karnauskas54% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | IMVT | Buy Now | Immunovant | $15.86 | 89.16% | Robyn Karnauskas54% | → $30 | Reiterates | Buy → Buy | Get Alert |
| 09/25/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.28 | 153.26% | Robyn Karnauskas54% | → $140 | Reiterates | Buy → Buy | Get Alert |
| 09/15/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.28 | 153.26% | Robyn Karnauskas54% | → $140 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2023 | PFE | Buy Now | Pfizer | $23.87 | 159.74% | Robyn Karnauskas54% | → $62 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | NCNA | Buy Now | NuCana | $0.12 | 4727.03% | Robyn Karnauskas54% | → $6 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | GILD | Buy Now | Gilead Sciences | $108.90 | -16.44% | Robyn Karnauskas54% | → $91 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 487.54% | Robyn Karnauskas54% | → $50 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2023 | AMGN | Buy Now | Amgen | $289.00 | -10.03% | Robyn Karnauskas54% | → $260 | Reiterates | Hold → Hold | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 103.47% | Robyn Karnauskas54% | → $1045 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | IMVT | Buy Now | Immunovant | $15.86 | 89.16% | Robyn Karnauskas54% | → $30 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | FATE | Buy Now | Fate Therapeutics | $1.26 | 455.56% | Robyn Karnauskas54% | → $7 | Reiterates | Hold → Hold | Get Alert |
| 08/16/2023 | ABSI | Buy Now | Absci | $2.78 | 259.71% | Robyn Karnauskas54% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 103.47% | Robyn Karnauskas54% | → $1045 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.73 | 1691.91% | Robyn Karnauskas54% | $71 → $31 | Maintains | Buy | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $782.91 | -23.36% | Robyn Karnauskas54% | $525 → $600 | Maintains | Buy | Get Alert |
| 08/08/2023 | BIIB | Buy Now | Biogen | $126.54 | 168.69% | Robyn Karnauskas54% | $350 → $340 | Maintains | Buy | Get Alert |
| 08/02/2023 | PFE | Buy Now | Pfizer | $23.87 | 159.74% | Robyn Karnauskas54% | $64 → $62 | Maintains | Buy | Get Alert |
| 08/02/2023 | MRK | Buy Now | Merck & Co | $78.70 | 55.02% | Robyn Karnauskas54% | $116 → $122 | Maintains | Buy | Get Alert |
| 07/24/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 1468.29% | Robyn Karnauskas54% | → $12 | Initiates | → Buy | Get Alert |
| 07/20/2023 | MRK | Buy Now | Merck & Co | $78.70 | 47.4% | Robyn Karnauskas54% | $118 → $116 | Maintains | Buy | Get Alert |
| 07/14/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | 102.64% | Robyn Karnauskas54% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 07/14/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 2513.82% | Robyn Karnauskas54% | $22 → $20 | Maintains | Buy | Get Alert |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.28 | 153.26% | Robyn Karnauskas54% | $125 → $140 | Maintains | Buy | Get Alert |
| 06/28/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 2775.2% | Robyn Karnauskas54% | → $22 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 103.47% | Robyn Karnauskas54% | $1050 → $1045 | Maintains | Buy | Get Alert |
| 06/27/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 104.45% | Robyn Karnauskas54% | → $1050 | Reiterates | Buy → Buy | Get Alert |
| 06/23/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | 102.64% | Robyn Karnauskas54% | $19 → $23 | Maintains | Buy | Get Alert |
| 06/20/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 2775.2% | Robyn Karnauskas54% | $24 → $22 | Maintains | Buy | Get Alert |
| 06/15/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 3036.58% | Robyn Karnauskas54% | → $24 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | QURE | Buy Now | uniQure | $14.50 | 279.31% | Robyn Karnauskas54% | $65 → $55 | Maintains | Buy | Get Alert |
| 05/03/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 104.45% | Robyn Karnauskas54% | $856 → $1050 | Maintains | Buy | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | 1.69% | Robyn Karnauskas54% | $341 → $456 | Maintains | Buy | Get Alert |
| 05/01/2023 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 3036.58% | Robyn Karnauskas54% | → $24 | Initiates | → Buy | Get Alert |
| 02/13/2023 | AMGN | Buy Now | Amgen | $289.00 | -10.03% | Robyn Karnauskas54% | $280 → $260 | Maintains | Hold | Get Alert |
| 02/09/2023 | ABBV | Buy Now | AbbVie | $185.00 | -2.7% | Robyn Karnauskas54% | → $180 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | MRK | Buy Now | Merck & Co | $78.70 | 49.94% | Robyn Karnauskas54% | $106 → $118 | Maintains | Buy | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.26 | 455.56% | Robyn Karnauskas54% | $46 → $7 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2023 | ABBV | Buy Now | AbbVie | $185.00 | -2.7% | Robyn Karnauskas54% | $160 → $180 | Maintains | Buy | Get Alert |
| 12/20/2022 | OABI | Buy Now | OmniAb | $1.73 | 478.03% | Robyn Karnauskas54% | → $10 | Initiates | → Buy | Get Alert |
| 12/13/2022 | FATE | Buy Now | Fate Therapeutics | $1.26 | 3550.79% | Robyn Karnauskas54% | $51 → $46 | Maintains | Buy | Get Alert |
| 12/06/2022 | MEIP | Buy Now | MEI Pharma | $2.27 | — | Robyn Karnauskas54% | — | Downgrade | Buy → Hold | Get Alert |
| 11/16/2022 | ABCL | Buy Now | AbCellera Biologics | $3.50 | 728.6% | Robyn Karnauskas54% | → $29 | Initiates | → Buy | Get Alert |
| 11/15/2022 | BIIB | Buy Now | Biogen | $126.54 | 176.59% | Robyn Karnauskas54% | $265 → $350 | Maintains | Buy | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $78.70 | 34.69% | Robyn Karnauskas54% | $103 → $106 | Maintains | Buy | Get Alert |
| 10/28/2022 | GILD | Buy Now | Gilead Sciences | $108.90 | -16.44% | Robyn Karnauskas54% | $76 → $91 | Upgrade | Hold → Buy | Get Alert |
| 09/22/2022 | BIIB | Buy Now | Biogen | $126.54 | 109.42% | Robyn Karnauskas54% | $270 → $265 | Maintains | Buy | Get Alert |
| 09/15/2022 | GILD | Buy Now | Gilead Sciences | $108.90 | -30.21% | Robyn Karnauskas54% | $71 → $76 | Maintains | Hold | Get Alert |
| 08/23/2022 | TIL | Buy Now | Instil Bio | $28.57 | -44% | Robyn Karnauskas54% | $25 → $16 | Maintains | Buy | Get Alert |
| 08/09/2022 | KOD | Buy Now | Kodiak Sciences | $3.53 | 324.93% | Robyn Karnauskas54% | $10 → $15 | Maintains | Buy | Get Alert |
| 07/29/2022 | ABBV | Buy Now | AbbVie | $185.00 | -13.51% | Robyn Karnauskas54% | → $160 | Reiterates | → Buy | Get Alert |
| 07/21/2022 | BIIB | Buy Now | Biogen | $126.54 | 113.37% | Robyn Karnauskas54% | $320 → $270 | Maintains | Buy | Get Alert |
| 07/18/2022 | ABSI | Buy Now | Absci | $2.78 | 187.77% | Robyn Karnauskas54% | → $8 | Initiates | → Buy | Get Alert |
| 07/08/2022 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 487.54% | Robyn Karnauskas54% | $77 → $50 | Maintains | Buy | Get Alert |
| 04/29/2022 | ABBV | Buy Now | AbbVie | $185.00 | -13.51% | Robyn Karnauskas54% | → $160 | Reiterates | → Buy | Get Alert |
| 03/31/2022 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Robyn Karnauskas54% | $12 → $4 | Maintains | Buy | Get Alert |
| 03/25/2022 | MEIP | Buy Now | MEI Pharma | $2.27 | 32.16% | Robyn Karnauskas54% | $8 → $3 | Maintains | Buy | Get Alert |
| 02/15/2022 | ABBV | Buy Now | AbbVie | $185.00 | -13.51% | Robyn Karnauskas54% | $135 → $160 | Maintains | Buy | Get Alert |
| 02/08/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 41.75% | Robyn Karnauskas54% | $754 → $728 | Maintains | Buy | Get Alert |
| 01/31/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 46.81% | Robyn Karnauskas54% | $756 → $754 | Maintains | Buy | Get Alert |
| 12/01/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -23.95% | Robyn Karnauskas54% | $331 → $341 | Maintains | Buy | Get Alert |
| 11/19/2021 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 522.8% | Robyn Karnauskas54% | $42 → $53 | Maintains | Buy | Get Alert |
| 11/08/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Robyn Karnauskas54% | $65 → $10 | Downgrade | Buy → Hold | Get Alert |
| 11/05/2021 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Robyn Karnauskas54% | $65 → $10 | Downgrade | Buy → Hold | Get Alert |
| 10/26/2021 | ROIV | Buy Now | Roivant Sciences | $11.35 | 32.16% | Robyn Karnauskas54% | → $15 | Initiates | → Buy | Get Alert |
| 08/06/2021 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Robyn Karnauskas54% | → $32 | Downgrade | Buy → Hold | Get Alert |
| 07/26/2021 | ABBV | Buy Now | AbbVie | $185.00 | -36.22% | Robyn Karnauskas54% | → $118 | Assumes | → Buy | Get Alert |
| 06/23/2021 | BTAI | Buy Now | BioXcel Therapeutics | $1.73 | 7125.43% | Robyn Karnauskas54% | $128 → $125 | Maintains | Buy | Get Alert |
| 06/14/2021 | BIIB | Buy Now | Biogen | $126.54 | 411.3% | Robyn Karnauskas54% | $458 → $647 | Maintains | Buy | Get Alert |
| 06/11/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -26.18% | Robyn Karnauskas54% | $305 → $331 | Maintains | Buy | Get Alert |
| 05/04/2021 | KOD | Buy Now | Kodiak Sciences | $3.53 | 4064.31% | Robyn Karnauskas54% | $89 → $147 | Maintains | Buy | Get Alert |
| 04/13/2021 | TIL | Buy Now | Instil Bio | $28.57 | 12.01% | Robyn Karnauskas54% | → $32 | Initiates | → Buy | Get Alert |
| 04/01/2021 | BTAI | Buy Now | BioXcel Therapeutics | $1.73 | 7241.04% | Robyn Karnauskas54% | $150 → $127 | Maintains | Buy | Get Alert |
| 03/18/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | Robyn Karnauskas54% | → $12 | Initiates | → Buy | Get Alert |
| 03/02/2021 | ATNX | Buy Now | Athenex | — | — | Robyn Karnauskas54% | $29 → $6 | Downgrade | Buy → Hold | Get Alert |
| 11/11/2020 | OPT | Buy Now | Opthea | $3.31 | 655.29% | Robyn Karnauskas54% | → $25 | Initiates | → Buy | Get Alert |
| 10/22/2020 | NCNA | Buy Now | NuCana | $0.12 | 17599.12% | Robyn Karnauskas54% | → $22 | Initiates | → Buy | Get Alert |
| 10/15/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -31.98% | Robyn Karnauskas54% | $330 → $305 | Maintains | Buy | Get Alert |
| 10/12/2020 | AMGN | Buy Now | Amgen | $289.00 | -13.15% | Robyn Karnauskas54% | $268 → $251 | Downgrade | Buy → Hold | Get Alert |
| 10/09/2020 | AMGN | Buy Now | Amgen | $289.00 | -13.15% | Robyn Karnauskas54% | $268 → $251 | Downgrade | Buy → Hold | Get Alert |
| 10/08/2020 | APLT | Buy Now | Applied Therapeutics | $0.36 | 23511.11% | Robyn Karnauskas54% | → $85 | Initiates | → Buy | Get Alert |
| 09/10/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.28 | 126.12% | Robyn Karnauskas54% | $130 → $125 | Maintains | Buy | Get Alert |
| 08/20/2020 | GILD | Buy Now | Gilead Sciences | $108.90 | -38.48% | Robyn Karnauskas54% | $74 → $67 | Maintains | Hold | Get Alert |
| 07/30/2020 | AMGN | Buy Now | Amgen | $289.00 | -7.27% | Robyn Karnauskas54% | $254 → $268 | Maintains | Buy | Get Alert |
| 07/28/2020 | KOD | Buy Now | Kodiak Sciences | $3.53 | 2421.25% | Robyn Karnauskas54% | $90 → $89 | Maintains | Buy | Get Alert |
| 07/09/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 46.03% | Robyn Karnauskas54% | $400 → $750 | Upgrade | Hold → Buy | Get Alert |
| 06/12/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -27.52% | Robyn Karnauskas54% | $305 → $325 | Maintains | Buy | Get Alert |
| 05/29/2020 | MEIP | Buy Now | MEI Pharma | $2.27 | 604.85% | Robyn Karnauskas54% | → $16 | Initiates | → Buy | Get Alert |
| 05/26/2020 | GILD | Buy Now | Gilead Sciences | $108.90 | -32.97% | Robyn Karnauskas54% | $70 → $73 | Upgrade | Sell → Hold | Get Alert |
| 05/18/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Robyn Karnauskas54% | $82 → $91 | Maintains | Buy | Get Alert |
| 05/14/2020 | KOD | Buy Now | Kodiak Sciences | $3.53 | 2449.58% | Robyn Karnauskas54% | $101 → $90 | Maintains | Buy | Get Alert |
| 05/01/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -31.98% | Robyn Karnauskas54% | $265 → $305 | Maintains | Buy | Get Alert |
| 04/29/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Robyn Karnauskas54% | $77 → $82 | Maintains | Buy | Get Alert |
| 04/23/2020 | BIIB | Buy Now | Biogen | $126.54 | 160.79% | Robyn Karnauskas54% | $360 → $330 | Maintains | Buy | Get Alert |
| 04/01/2020 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 158.52% | Robyn Karnauskas54% | $20 → $22 | Maintains | Buy | Get Alert |
| 02/14/2020 | BTAI | Buy Now | BioXcel Therapeutics | $1.73 | 8570.52% | Robyn Karnauskas54% | $24 → $150 | Maintains | Buy | Get Alert |
| 02/06/2020 | KOD | Buy Now | Kodiak Sciences | $3.53 | 2761.19% | Robyn Karnauskas54% | → $101 | Initiates | → Buy | Get Alert |
| 02/03/2020 | BIIB | Buy Now | Biogen | $126.54 | 184.5% | Robyn Karnauskas54% | $337 → $360 | Maintains | Buy | Get Alert |
| 02/03/2020 | AMGN | Buy Now | Amgen | $289.00 | -8.3% | Robyn Karnauskas54% | $254 → $265 | Maintains | Buy | Get Alert |
| 01/13/2020 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Robyn Karnauskas54% | → $77 | Initiates | → Buy | Get Alert |
| 01/10/2020 | IMVT | Buy Now | Immunovant | $15.86 | 51.32% | Robyn Karnauskas54% | → $24 | Initiates | → Buy | Get Alert |
| 11/12/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | -29.9% | Robyn Karnauskas54% | → $360 | Initiates | → Hold | Get Alert |
| 11/12/2019 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 135.02% | Robyn Karnauskas54% | → $20 | Initiates | → Buy | Get Alert |
| 11/12/2019 | GILD | Buy Now | Gilead Sciences | $108.90 | -35.72% | Robyn Karnauskas54% | → $70 | Initiates | → Hold | Get Alert |
| 11/12/2019 | BTAI | Buy Now | BioXcel Therapeutics | $1.73 | 1287.28% | Robyn Karnauskas54% | → $24 | Initiates | → Buy | Get Alert |
| 11/12/2019 | BIIB | Buy Now | Biogen | $126.54 | 166.32% | Robyn Karnauskas54% | → $337 | Initiates | → Buy | Get Alert |
| 11/12/2019 | AMGN | Buy Now | Amgen | $289.00 | -11.42% | Robyn Karnauskas54% | → $256 | Initiates | → Buy | Get Alert |
| 11/07/2019 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 3951.42% | Robyn Karnauskas54% | $27 → $31 | Maintains | Buy | Get Alert |
| 10/22/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -49.82% | Robyn Karnauskas54% | $205 → $225 | Maintains | Buy | Get Alert |
| 05/24/2019 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Robyn Karnauskas54% | → $30 | Assumes | → Buy | Get Alert |
| 05/24/2019 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 193.77% | Robyn Karnauskas54% | → $25 | Assumes | → Buy | Get Alert |
| 05/23/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Robyn Karnauskas54% | $180 → $165 | Maintains | Buy | Get Alert |
| 05/23/2019 | GILD | Buy Now | Gilead Sciences | $108.90 | — | Robyn Karnauskas54% | — | Upgrade | Neutral → Buy | Get Alert |
| 03/22/2019 | BIIB | Buy Now | Biogen | $126.54 | 81.76% | Robyn Karnauskas54% | $470 → $230 | Downgrade | Buy → Neutral | Get Alert |
| 02/12/2019 | GILD | Buy Now | Gilead Sciences | $108.90 | -31.13% | Robyn Karnauskas54% | $100 → $75 | Downgrade | Buy → Neutral | Get Alert |
| 01/04/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -54.28% | Robyn Karnauskas54% | $206 → $205 | Maintains | Buy | Get Alert |
| 12/17/2018 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $100 → $77 | Maintains | Neutral | Get Alert |
| 10/30/2018 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Robyn Karnauskas54% | $27 → $30 | Maintains | Buy | Get Alert |
| 10/25/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Robyn Karnauskas54% | $195 → $190 | Maintains | Buy | Get Alert |
| 09/25/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Robyn Karnauskas54% | $173 → $195 | Maintains | Buy | Get Alert |
| 09/13/2018 | DRNA | Buy Now | Dicerna Pharmaceuticals | — | — | Robyn Karnauskas54% | → $27 | Initiates | → Buy | Get Alert |
| 08/20/2018 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Robyn Karnauskas54% | $60 → $44 | Maintains | Buy | Get Alert |
| 08/09/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $55.28 | 117.08% | Robyn Karnauskas54% | $108 → $120 | Maintains | Buy | Get Alert |
| 07/30/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -54.06% | Robyn Karnauskas54% | $203 → $206 | Maintains | Buy | Get Alert |
| 07/13/2018 | MEIP | Buy Now | MEI Pharma | $2.27 | 428.63% | Robyn Karnauskas54% | → $12 | Initiates | → Buy | Get Alert |
| 07/06/2018 | BIIB | Buy Now | Biogen | $126.54 | 193.19% | Robyn Karnauskas54% | → $371 | Upgrade | Neutral → Buy | Get Alert |
| 05/02/2018 | BIIB | Buy Now | Biogen | $126.54 | 129.18% | Robyn Karnauskas54% | $360 → $290 | Maintains | Neutral | Get Alert |
| 04/30/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Robyn Karnauskas54% | $170 → $173 | Maintains | Buy | Get Alert |
| 04/09/2018 | RCUS | Buy Now | Arcus Biosciences | $8.51 | 193.77% | Robyn Karnauskas54% | → $25 | Initiates | → Buy | Get Alert |
| 03/09/2018 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 3167.27% | Robyn Karnauskas54% | $23 → $25 | Maintains | Buy | Get Alert |
| 03/01/2018 | XLRN | Buy Now | Acceleron Pharma | — | — | Robyn Karnauskas54% | $44 → $63 | Maintains | Buy | Get Alert |
| 02/16/2018 | CALA | Buy Now | Calithera Biosciences | $0.00 | — | Robyn Karnauskas54% | — | Upgrade | Neutral → Buy | Get Alert |
| 02/09/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Robyn Karnauskas54% | $173 → $170 | Maintains | Buy | Get Alert |
| 01/30/2018 | GILD | Buy Now | Gilead Sciences | $108.90 | — | Robyn Karnauskas54% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/18/2018 | JUNO | Buy Now | Juno Therapeutics | — | — | Robyn Karnauskas54% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/01/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | — | Robyn Karnauskas54% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/27/2017 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $140 → $102 | Maintains | Neutral | Get Alert |
| 10/23/2017 | BIIB | Buy Now | Biogen | $126.54 | — | Robyn Karnauskas54% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/20/2017 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/20/2017 | BIIB | Buy Now | Biogen | $126.54 | 184.5% | Robyn Karnauskas54% | → $360 | Initiates | → Buy | Get Alert |
| 07/19/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $448.40 | -57.63% | Robyn Karnauskas54% | $135 → $190 | Maintains | Buy | Get Alert |
| 03/02/2017 | KITE | Buy Now | Kite Pharma | — | — | Robyn Karnauskas54% | $62 → $87 | Downgrade | Buy → Neutral | Get Alert |
| 03/02/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Robyn Karnauskas54% | $40 → $36 | Upgrade | Neutral → Buy | Get Alert |
| 02/08/2017 | GILD | Buy Now | Gilead Sciences | $108.90 | -30.21% | Robyn Karnauskas54% | $87 → $76 | Downgrade | Buy → Neutral | Get Alert |
| 02/08/2017 | BIIB | Buy Now | Biogen | $126.54 | — | Robyn Karnauskas54% | — | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2017 | BIIB | Buy Now | Biogen | $126.54 | — | Robyn Karnauskas54% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/24/2017 | CALA | Buy Now | Calithera Biosciences | $0.00 | — | Robyn Karnauskas54% | — | Upgrade | Sell → Neutral | Get Alert |
| 10/25/2016 | CALA | Buy Now | Calithera Biosciences | $0.00 | — | Robyn Karnauskas54% | — | Initiates | → Sell | Get Alert |
| 10/25/2016 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Robyn Karnauskas54% | — | Initiates | → Buy | Get Alert |
| 09/29/2016 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $124 → $127 | Maintains | Buy | Get Alert |
| 09/29/2016 | XLRN | Buy Now | Acceleron Pharma | — | — | Robyn Karnauskas54% | → $40 | Initiates | → Neutral | Get Alert |
| 07/27/2016 | CHRS | Buy Now | Coherus BioSciences | $0.77 | 4604.87% | Robyn Karnauskas54% | → $36 | Initiates | → Buy | Get Alert |
| 04/29/2016 | GILD | Buy Now | Gilead Sciences | $108.90 | -3.58% | Robyn Karnauskas54% | $110 → $105 | Maintains | Buy | Get Alert |
| 03/03/2016 | JMI | Buy Now | JAVELIN Mortgage | — | — | Robyn Karnauskas54% | $6 → $7.14 | Upgrade | Sell → Neutral | Get Alert |
| 03/02/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | -12.38% | Robyn Karnauskas54% | → $450 | Initiates | → Neutral | Get Alert |
| 02/25/2016 | JUNO | Buy Now | Juno Therapeutics | — | — | Robyn Karnauskas54% | — | Initiates | → Buy | Get Alert |
| 02/25/2016 | GILD | Buy Now | Gilead Sciences | $108.90 | — | Robyn Karnauskas54% | — | Initiates | → Buy | Get Alert |
| 02/25/2016 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | — | Initiates | → Buy | Get Alert |
| 07/31/2015 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Robyn Karnauskas54% | → $33 | Initiates | → Buy | Get Alert |
| 02/05/2015 | GILD | Buy Now | Gilead Sciences | $108.90 | 10.19% | Robyn Karnauskas54% | $125 → $120 | Maintains | Buy | Get Alert |
| 01/30/2015 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $119 → $143 | Maintains | Buy | Get Alert |
| 10/24/2014 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $99.5 → $119 | Maintains | Buy | Get Alert |
| 09/19/2014 | GILD | Buy Now | Gilead Sciences | $108.90 | 27.64% | Robyn Karnauskas54% | $111 → $139 | Maintains | Buy | Get Alert |
| 01/06/2014 | GILD | Buy Now | Gilead Sciences | $108.90 | -11.85% | Robyn Karnauskas54% | $87 → $96 | — | — | Get Alert |
| 12/06/2013 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $182 → $204 | Maintains | Buy | Get Alert |
| 11/20/2013 | GILD | Buy Now | Gilead Sciences | $108.90 | -20.11% | Robyn Karnauskas54% | $85 → $87 | Maintains | Buy | Get Alert |
| 04/19/2013 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $114 → $140 | Maintains | Buy | Get Alert |
| 03/18/2013 | GILD | Buy Now | Gilead Sciences | $108.90 | -44.9% | Robyn Karnauskas54% | $46 → $60 | Maintains | Buy | Get Alert |
| 01/25/2013 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $93 → $114 | Maintains | Buy | Get Alert |
| 06/21/2012 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | $84 → $78 | Maintains | Buy | Get Alert |
| 12/12/2011 | CELG | Buy Now | Celgene | — | — | Robyn Karnauskas54% | — | Maintains | Buy | Get Alert |
